SCHEMBL7817820

SCHEMBL7817820

CCOC(=O)C1CNc2cc(C)ccc2O1

nearest known ligand 0.60

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 2/20 0.60
KMT2A Q03164 4/20 0.58
HPGD P15428 2/20 0.58
CYP1A2 P05177 1/20 0.58
CYP3A4 P08684 1/20 0.58
CYP2C9 P11712 1/20 0.58
CYP2C19 P33261 1/20 0.58
SMN1; SMN2 Q16637 1/20 0.57
CYP4F2 P78329 1/20 0.47
CYP4A11 Q02928 1/20 0.47
ALDH1A1 P00352 4/20 0.45
POLB P06746 1/20 0.43
GAA P10253 2/20 0.43
USP2 O75604 1/20 0.43
BRD4 O60885 1/20 0.40
CREBBP Q92793 1/20 0.40
MEN1 O00255 2/20 0.39
MAPT P10636 1/20 0.39
TSHR P16473 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL11562060 0.99 HSD17B10 (0.59) HSD17B10KMT2AHPGDCYP1A2CYP3A4
SCHEMBL2577554 0.90 HSD17B10 (0.48) HSD17B10KMT2AHPGDCYP1A2CYP3A4
SCHEMBL750101 0.87 HSD17B10 (0.46) HSD17B10KMT2AHPGDCYP1A2CYP3A4
SCHEMBL13675536 0.87 HSD17B10 (0.46) HSD17B10KMT2AHPGDCYP1A2CYP3A4
SCHEMBL3353094 0.87 POLB (0.55) HSD17B10KMT2AHPGDCYP1A2CYP3A4
SCHEMBL7819909 0.87 HSD17B10 (0.46) HSD17B10KMT2AHPGDCYP1A2CYP3A4
SCHEMBL29527171 0.87 POLB (0.55) HSD17B10KMT2AHPGDCYP1A2CYP3A4
SCHEMBL23420329 0.86 HSD17B10 (0.46) HSD17B10KMT2AHPGDCYP1A2CYP3A4
Hydrochloric Acid SCHEMBL11561609 0.86 HSD17B10 (0.46) HSD17B10KMT2AHPGDCYP1A2CYP3A4
SCHEMBL7818765 0.86 ALDH1A1 (0.48) HSD17B10KMT2AHPGDCYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022087433-A1 COVALENT INHIBITORS OF CREATINE KINASE (CK) AND USES THEREOF FOR TREATING AND PREVENTING CANCER DANA-FARBER CANCER INSTITUTE, INC. (US) 2022-04-28 WO disclosed
WO-2016006593-A1 NOVEL BENZOXAZINE DERIVATIVE AND MEDICINE COMPRISING SAME 国立研究開発法人国立長寿医療研究センター 2016-01-14 WO disclosed
EP-0894796-B1 Imidazolines substituted with a heterocyclic ring as alpha-2 antagonists ADIR (FR) 2001-06-06 EP disclosed
US-6057317-A Heterocyclic compounds ADIR ET COMPAGNIE (FR) 2000-05-02 US disclosed
EP-0894796-A1 Imidazolines substituted with a heterocyclic ring as alpha-2 antagonists ADIR ET COMPAGNIE (FR) 1999-02-03 EP disclosed